64 completed, 28 recruiting, 16 terminated, 6 active not recruiting. 53 Not applicable, 30 Phase 2, 9 Phase 3, 3 Phase 1, 2 Phase 4.
Follow Centre Francois Baclesse: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Probiotics on Neuropathy Induced by Adjuvant Chemotherapy in Patients With Colon Cancer. PROBIOTIC SUPPLEMENTATION BY OXXYSLAB®, PLACEBO supplementation - Colon Adenocarcinoma, Neuropathic Pain | Not applicable | Not yet recruiting | Centre Francois Baclesse | 130 | 2026-10-01 | 2026-07-30 |
| Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management Adapted Onco-Esthetics sessions - Oncology, Aerodigestive Tract Cancer | Not applicable | Recruiting | Centre Francois Baclesse | 55 | 2025-10-24 | 2026-03-12 |
| Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma cabozantinib and nivolumab - Renal Cell Carcinoma (Kidney Cancer), Metastatic Renal Cell Carcinoma | Phase 4 | Recruiting | Centre Francois Baclesse | 83 | 2025-10-01 | 2026-07-14 |
| MEASUREMENT OF CIRCULATING MUTATION BURDEN Mutation Burden cfMB analysis - Breast Carcinoma, Genetic Predisposition to Cancer | Recruiting | Centre Francois Baclesse | 30 | 2025-07-04 | 2025-07-08 | |
| Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer: transcutaneous auricular vagus nerve stimulation, Placebo device - Ovarian Carcinoma, First Line Chemotherapy | Phase 3 | Recruiting | Centre Francois Baclesse | 116 | 2025-04-30 | 2025-10-07 |
| Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions organoid etablishment - Undifferentiated Carcinoma | Recruiting | Centre Francois Baclesse | 20 | 2025-03-05 | 2025-12-24 | |
| Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers Standard post-operative radiotherapy without flap sparing (current practice), Post-operative radiotherapy with flap sparing - Oral Cavity Carcinoma, Flap | Phase 3 | Recruiting | Centre Francois Baclesse | 348 | 2025-03-01 | 2026-10-27 |
| Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study tumour and blood samples - Endometrial Cancer | Recruiting | Centre Francois Baclesse | 16 | 2024-11-21 | 2024-11-26 | |
| Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer Multidisciplinary assessment, Standard assesment, Observational cohort - Gynecologic Cancer, Remission | Not applicable | Recruiting | Centre Francois Baclesse | 268 | 2024-06-07 | 2026-09-24 |
| Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity Virtual Reality sessions - Breast Cancer, Cancer-related Cognitive Difficulties | Not applicable | Completed | Centre Francois Baclesse | 23 | 2024-05-23 | 2026-02-10 |
| Benefit of Adding Cureety TechCare Telemonitoring to Usual Care During Injectable Anticancer Treatment Cureety telemonitoring, OPTIMA or equivalent programs - Adult Patients Initiating Injectable Anticancer | Not applicable | Completed | Centre Francois Baclesse | 192 | 2024-04-03 | 2025-09-22 |
| Efficacy of Adapted Physical Activity on a Walking Platform in Elderly Patients HOspitalized for Cancer Surgery Early rehabilitation through Adapted Physical Activity - Oncology, Elderly Patients | Phase 2 | Recruiting | Centre Francois Baclesse | 60 | 2024-03-15 | 2026-01-12 |
| Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery Radiotherapy in painting dose on histoscannographic mapping, Standard pan-sinusal Radiotherapy - Tumor, Solid | Phase 2 | Recruiting | Centre Francois Baclesse | 52 | 2024-03-11 | 2026-07-02 |
| Long-term Cognitive and Functional Impact of Proton-therapy or Modern Fractionated Radiotherapy in Cavernous Sinus Meningioma: An Open-label Randomized 1:1 Phase III Study Proton-therapy, Photon radiotherapy - Cavernous Sinus Meningioma, Proton-therapy | Not applicable | Recruiting | Centre Francois Baclesse | 160 | 2024-02-26 | 2025-09-29 |
| HRD Tests for Ovarian cancER tests to determine HRD status - Ovarian Cancer | Phase 2 | Recruiting | Centre Francois Baclesse | 88 | 2024-02-15 | 2025-09-17 |
| Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer Cognitive exercises with supervision, Cognitive exercises without supervision - Breast Cancer, Cognitive Dysfunction | Not applicable | Recruiting | Centre Francois Baclesse | 300 | 2024-02-09 | 2025-09-19 |
| Shared Meditation Involving People With Cancer, Carers and Third Parties Shared meditation, Meditation with patients oly - Patients With Cancer | Not applicable | Completed | Centre Francois Baclesse | 96 | 2024-01-09 | 2024-07-11 |
| Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology Blood sample - Radiosensitivity, Pediatric Cancer | Not applicable | Recruiting | Neolys | 100 | 2023-12-02 | 2024-11-22 |
| Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT Screening for atrial fibrillation and other cardiac arrhythmias and diseases - Breast Cancer, Radiation Toxicity | Unknown | Sophie JACOB | 200 | 2023-10-25 | 2023-11-08 | |
| Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma: Normo-fractionated intensity-modulated brain irradiation with or without stereotactic positioning, Hypo-fractionated stereotactic brain irradiation, Normo-fractionated proton therapy brain irradiation - Meningioma, Radiation Toxicity | Not applicable | Recruiting | Centre Francois Baclesse | 108 | 2023-09-13 | 2025-06-24 |
Showing 20 of 123. Sign in to see all of them.
Neoplasms (29) · Breast Neoplasms (25) · Head and Neck Neoplasms (10) · Ovarian Neoplasms (10) · Brain Neoplasms (6) · Neoplasm Metastasis (6) · Radiation Injuries (4) · Carcinoma, Renal Cell (3) · Cognitive Dysfunction (3) · Fatigue (3) · Atrial Fibrillation (2) · COVID-19 (2) · Colonic Neoplasms (2) · Endometrial Neoplasms (2) · Hyperparathyroidism (2)
Blood Specimen Collection (9) · Surveys and Questionnaires (4) · Carboplatin (3) · Radiotherapy (3) · Bevacizumab (2) · Filgrastim (2) · Meditation (2) · Radiotherapy, Intensity-Modulated (2) · cabozantinib (2) · Aspirin (1) · Auriculotherapy (1) · Brachytherapy (1) · Diagnosis (1) · Drug Therapy (1) · Equipment and Supplies (1)
France (122) · Belgium (2) · Denmark (1) · Germany (1)
Beate Timmermann, MD (1) · Boutros Mariam (1)
PMID 41979169, PMID 18397244, PMID 19398490, PMID 19653045, PMID 20837830, PMID 23129676, PMID 25117521, PMID 25214508, PMID 25274615, PMID 27992617, PMID 28814281, PMID 29270788, PMID 29635147, PMID 30176833, PMID 31286871, PMID 32087691, PMID 32193623, PMID 32638211, PMID 33183159, PMID 33215294, PMID 33413316, PMID 34563169, PMID 34772746, PMID 35123771, PMID 35344040, PMID 35500434, PMID 35549674, PMID 35585593, PMID 36434554, PMID 36513991, PMID 36801605, PMID 36812938, PMID 36894916, PMID 37452577, PMID 37559004, PMID 37726786, PMID 37757587, PMID 38041077, PMID 38425504, PMID 38822324, PMID 38830303, PMID 38849726, PMID 38900416, PMID 39083526, PMID 39232668, PMID 39369231, PMID 39736544, PMID 39881369, PMID 39882966, PMID 39934735
2019 (2), 2009 (1), 2015 (1), 2016 (1), 2017 (1)